Suppr超能文献

[儿童期起病肌张力障碍的多种病因]

[The varied etiologies of childhood-onset dystonia].

作者信息

Roubertie A, Rivier F, Humbertclaude V, Tuffery S, Cavalier L, Cheminal R, Coubes P, Echenne B

机构信息

Service de Neuropédiatrie, Hôpital Saint Eloi, CHU de Montpellier, France.

出版信息

Rev Neurol (Paris). 2002 Apr;158(4):413-24.

Abstract

Dystonia is not uncommon in childhood, and identification of its etiology is an ultimate aim in the clinical evaluation of dystonia. Advances in neuroimaging, recent identification of gene or loci implicated in dystonic syndromes, and characterisation of new pathological entities (creatine deficiency, biotin-responsive basal ganglia disease) enlarge our understanding of childhood dystonia, and expend its diagnosis spectrum. Awareness of the diverse etiologic categories of childhood-onset dystonia is necessary to accurate diagnosis approach. Clinical examination and cerebral magnetic resonance imaging are the keys of this diagnosis approach. Primary dystonia is defined as syndromes in which dystonia is the sole phenotypic manifestation (especially no cognitive deterioration is observed, and brain MRI is normal); DYT1 dystonia, in which the abnormal gene is located on chromosome 9, is the most frequent childhood-onset primary dystonia; progressive generalisation of the abnormal movements occur in 70p.cent of the patients. Dopa - Responsive Dystonia are characterized by marked diurnal fluctuations of the dystonic symptoms and by their marked and sustained response to dopaminergic therapy; associated parkinsonian signs are usually observed later in the course of the disease. Clinical presentation of DRD might be atypical (mimicking cerebral palsy or isolated limb pain without diurnal fluctuation). DRD is rare, but a trial of L-dopa should be performed on all patients with childhood-onset dystonia, lasting at least one month. Secondary dystonias or heredodegenerative diseases are the most frequent etiology of childhood-onset dystonic syndromes. Among a huge range of heredodegenerative disease, those that are amenable to a specific treatment, such as Wilson's disease or creatine deficiency, should be particularly investigated. The main objective of investigation of dystonia is to identify secondary dystonias or heredodegenerative diseases. Further investigations will be performed according to the clinical characteristics of the dystonia, to the presence of associated neurological or extraneurological symptoms, and according to brain imaging; this approach must be discussed for each single patient. The aim of the diagnosis strategy is the rapid identification of the etiology of dystonia which will lead to accurate treatment and pertinent genetic counselling.

摘要

肌张力障碍在儿童期并不罕见,确定其病因是肌张力障碍临床评估的最终目标。神经影像学的进展、近期对与肌张力障碍综合征相关的基因或基因座的鉴定以及新的病理实体(肌酸缺乏、生物素反应性基底节疾病)的特征描述,拓宽了我们对儿童肌张力障碍的认识,并扩大了其诊断范围。了解儿童期起病的肌张力障碍的不同病因类别对于准确的诊断方法至关重要。临床检查和脑磁共振成像为此诊断方法的关键。原发性肌张力障碍被定义为肌张力障碍是唯一表型表现的综合征(尤其是未观察到认知功能恶化且脑MRI正常);DYT1肌张力障碍,其异常基因位于9号染色体上,是最常见的儿童期起病的原发性肌张力障碍;70%的患者会出现异常运动的进行性泛化。多巴反应性肌张力障碍的特点是肌张力障碍症状有明显的昼夜波动,以及对多巴胺能治疗有显著且持续的反应;相关的帕金森样体征通常在疾病后期出现。多巴反应性肌张力障碍的临床表现可能不典型(模仿脑瘫或无昼夜波动的孤立肢体疼痛)。多巴反应性肌张力障碍很少见,但应对所有儿童期起病的肌张力障碍患者进行左旋多巴试验,持续至少一个月。继发性肌张力障碍或遗传性退行性疾病是儿童期起病的肌张力障碍综合征最常见的病因。在众多遗传性退行性疾病中,那些适合特定治疗的疾病,如威尔逊病或肌酸缺乏,应特别予以研究。肌张力障碍调查的主要目的是识别继发性肌张力障碍或遗传性退行性疾病。将根据肌张力障碍的临床特征、是否存在相关的神经或神经外症状以及脑成像进行进一步检查;必须针对每个患者讨论这种方法。诊断策略的目的是快速确定肌张力障碍的病因,从而实现准确的治疗和相关的遗传咨询。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验